← Back to Search

App-Based Mindfulness for Kidney Cancer

N/A
Waitlist Available
Led By Sumanta K Pal
Research Sponsored by City of Hope Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Not suffering from current major depressive disorder, bipolar disorder or other psychiatric disorder
Evidence of metastatic disease (including at a minimum computed tomography [CT] of the chest, abdomen and pelvis for staging)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing whether an app-based mindfulness intervention can help improve quality of life for patients with metastatic renal cell cancer.

Who is the study for?
This trial is for patients with metastatic renal cell carcinoma who haven't practiced meditation regularly in the past year, have a significant fear of cancer progression, and have not been part of mindfulness-based recovery or stress reduction programs within 5 years. Participants must own a smartphone with internet access, be fluent in English, and currently be receiving immunotherapy.
What is being tested?
The study tests an app-based mindfulness program to see if it can improve life quality for those with advanced kidney cancer. It involves using the app to engage in mindfulness exercises and completing questionnaires about their experience and feelings.
What are the potential side effects?
Since this intervention is behavioral involving mindfulness practices through an app, there are no direct medical side effects like you would expect from medication or surgery. However, participants may experience emotional discomfort when confronting fears related to their illness.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have major depression, bipolar, or other severe mental health issues.
Select...
My cancer has spread, confirmed by CT scans of my chest, abdomen, and pelvis.
Select...
I am currently receiving immunotherapy.
Select...
My kidney cancer diagnosis was confirmed through lab tests.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Brief Fatigue Inventory (BFI): Fatigue Interferance
Brief Fatigue Inventory (BFI): Fatigue severity
Fear of Cancer Recurrence-7
+12 more

Side effects data

From 2013 Phase 1 & 2 trial • 16 Patients • NCT01923896
13%
Diarrhea
100%
80%
60%
40%
20%
0%
Study treatment Arm
Behavioral Intervention & DCS
Behavioral Intervention & Placebo

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Device feasibility (app-based mindfulness program)Experimental Treatment3 Interventions
Patients participate in a mindfulness-based program by using the Am app for 20-30 minutes every day, a minimum of 4 days each week over 4 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Behavioral Intervention
2021
Completed Phase 4
~3740

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,559 Total Patients Enrolled
City of Hope Medical CenterLead Sponsor
605 Previous Clinical Trials
1,923,584 Total Patients Enrolled
Sumanta K PalPrincipal InvestigatorCity of Hope Medical Center
9 Previous Clinical Trials
332 Total Patients Enrolled

Media Library

App-Based Mindfulness Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04788095 — N/A
Kidney Cancer Research Study Groups: Device feasibility (app-based mindfulness program)
Kidney Cancer Clinical Trial 2023: App-Based Mindfulness Intervention Highlights & Side Effects. Trial Name: NCT04788095 — N/A
App-Based Mindfulness Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04788095 — N/A
~5 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top